Overview
A Drug-drug Interaction Study of DP-R213
Status:
Completed
Completed
Trial end date:
2016-03-01
2016-03-01
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
The purpose of this study is to learn about the effect of raloxifene on how the body absorbs and processes cholecalciferol and how cholecalciferol affects raloxifene when they are taken together.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Alvogen KoreaTreatments:
Cholecalciferol
Raloxifene Hydrochloride
Criteria
Inclusion Criteria:- Healthy male volunteer, age above 19
- The result of Ideal Body Weight(IBW) is not less than -20%, no more than +20%
- Subject who has the ability to comprehend the study objectives, contents and the
property of the study drug before participating in the trial.
Exclusion Criteria:
- Presence of medical history or a concurrent disease that may interfere with treatment
and safety assessment in completion of this clinical study
- Treatment history of other drugs within last 10 days